← Leaderboards
Shirley M Tsunoda
University Of California, San Diego
$1,176,383
Attributed
$1,176,383
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $8.5M · FY2021–25$10M$7.5M$5M$2.5M$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$15,282,881 · 2
By mechanism
P50$15,282,881 · 2
Top collaborators
- Lars Bode8 shared
- Christina Chambers8 shared
- Victor Nizet8 shared
- Adriana H Tremoulet8 shared
Most similar at University Of California, San Diego
Same institution · by research overlap
- Victor Nizet$31,303,620
- Adriana H Tremoulet$8,401,727
- Liangfang Zhang$5,562,722
- George Sakoulas$657,135
- Ellen Eun-Ok Lee$2,507,968
Others in their field
Other Emerging Leaders on “Innovation”
- Klaus Romero · Critical Path Institute$86,053,372
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$71,439,892
- Ted Ross · University Of Georgia$70,992,558
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$69,953,681
- Tony Moody · Duke University$65,625,959
- Matthew Johnson · Duke University$60,590,296
Research focus
InnovationMilkHepaticInfectionMetabolicMicrobiomeAntibioticsExposure ToHuman MilkInfant MonitoringMass Spectrum AnalysisBasic ScienceMetabolomeMetabolomicsBreastfed InfantBreast FeedingAmpicillinEnzymesAnalytical ChemistryData ScienceCytochrome P450InfantEnzyme ActivityMolecular
Grant awards (13)
Optimization of Antibiotics in Mothers and their Breastfed Infants Using Pharmacomicrobiomic and Metabolomic Analyses$1,190,453
P50 · FY2025 · HD
Impact of Maternal Antibiotics on the Breastfeeding Infant Microbiome and Metabolome$210,424
P50 · FY2025 · HD · contact PI
Optimization of Antibiotics in Mothers and their Breastfed Infants Using Pharmacomicrobiomic and Metabolomic Analyses$3,465,000
P50 · FY2024 · HD
Optimization of Antibiotics in Mothers and their Breastfed Infants Using Pharmacomicrobiomic and Metabolomic Analyses$3,465,000
P50 · FY2024 · HD
Optimization of Antibiotics in Mothers and their Breastfed Infants Using Pharmacomicrobiomic and Metabolomic Analyses$1,231,207
P50 · FY2024 · HD
Impact of Maternal Antibiotics on the Breastfeeding Infant Microbiome and Metabolome$338,824
P50 · FY2024 · HD · contact PI
Optimization of Antibiotics in Mothers and their Breastfed Infants Using Pharmacomicrobiomic and Metabolomic Analyses$1,239,102
P50 · FY2023 · HD
Impact of Maternal Antibiotics on the Breastfeeding Infant Microbiome and Metabolome$210,424
P50 · FY2023 · HD · contact PI
Optimization of Antibiotics in Mothers and their Breastfed Infants Using Pharmacomicrobiomic and Metabolomic Analyses$1,250,000
P50 · FY2022 · HD
Optimization of Antibiotics in Mothers and their Breastfed Infants Using Pharmacomicrobiomic and Metabolomic Analyses$1,015,736
P50 · FY2022 · HD
Impact of Maternal Antibiotics on the Breastfeeding Infant Microbiome and Metabolome$206,549
P50 · FY2022 · HD · contact PI
Optimization of Antibiotics in Mothers and their Breastfed Infants Using Pharmacomicrobiomic and Metabolomic Analyses$1,250,000
P50 · FY2021 · HD
Impact of Maternal Antibiotics on the Breastfeeding Infant Microbiome and Metabolome$210,162
P50 · FY2021 · HD · contact PI